Mineralys Therapeutics Inc

NAS:MLYSHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$21.61+3.27%LiveIn session · ≈ AED 79.34 · Market cap $1.91B · Next earnings Mon 9 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Return on equity	95.2%	84.7%	57.0%	−29.8%	−93.0%	−23.9%	−23.9%	+0.0 pts
Return on assets	−230.6%	−174.5%	−26.0%	−28.6%	−86.4%	−23.4%	−23.4%	+0.0 pts
Return on capital employed	81.8%	−308.4%	−29.6%	−35.1%	−100.6%	−26.4%	—	—
Debt / equity	−1.3×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—
Debt / assets	302.8%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—
Interest coverage	−25.6×	−693.5×	−18.8×	0.0×	0.0×	0.0×	—	—
Current ratio	0.3×	2.2×	14.0×	23.8×	14.0×	43.8×	43.8×	+0.0%
Quick ratio	0.3×	2.2×	14.0×	23.8×	14.0×	43.8×	—	—
Cash ratio	0.3×	2.1×	10.9×	4.7×	7.8×	11.4×	11.4×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.